Drugs in Development for Acute Kidney Injury

The care of patients with acute kidney injury (AKI) has been limited due to the lack of effective therapeutics that can either prevent AKI during high-risk situations or treat AKI once established. A revolution in the scientific understanding of the pathogenesis of AKI has led to the identification...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs (New York, N.Y.) N.Y.), 2019-06, Vol.79 (8), p.811-821
Hauptverfasser:	Hulse, Matthew, Rosner, Mitchell H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Clinical trials Disease prevention Drug development Fibrosis Heart surgery Hemodynamics Hospitalization Injury prevention Internal Medicine Kidney diseases Kidneys Leading Article Medical research Medicine Medicine & Public Health Metabolism Mitochondria Mortality Oxidative metabolism Oxidative stress Pathogenesis Patients Pharmacology/Toxicology Pharmacotherapy Phenotyping Renal replacement therapy Sepsis Target recognition Therapeutic applications Transplants & implants Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!